Skip to main content
Erschienen in: Journal of Clinical Immunology 2/2009

01.03.2009

Long-Term Neurocognitive Function of Pediatric Patients with Severe Combined Immune Deficiency (SCID): Pre- and Post-Hematopoietic Stem Cell Transplant (HSCT)

verfasst von: Malinda Lin, Karen Epport, Colleen Azen, Robertson Parkman, Donald B. Kohn, Ami J. Shah

Erschienen in: Journal of Clinical Immunology | Ausgabe 2/2009

Einloggen, um Zugang zu erhalten

Abstract

Background

Hematopoietic stem cell transplantation (HSCT) is the only cure for patients with severe combined immunodeficiency (SCID). The purpose of this study was to evaluate long-term neurodevelopment of patients with SCID following myeloablative chemotherapy and HSCT.

Materials and Methods

Sixteen pediatric patients diagnosed with SCID were tested using the Bayley Scales of Infant Development and the validated Vineland Adaptive Behavior Scales (VABS) pre- and 1-year post-HSCT. Three years post-HSCT, there were 11 patients available for testing and four patients available 5 years post-HSCT. Patients greater than 3 years of age were administered the Wechsler Preschool and Primary Scale of Intelligence. Both raw scores and scaled scores were analyzed.

Results

There was a significant decrease 1 year post-HSCT in the Bayley Mental Developmental Index (MDI) [92.5 (pre) vs. 70.81 (1 year post), p < 0.0001] and the VABS [99.73 (pre) vs. 79.87 (1 year post), p = <0.0001]. There was a significant decrease over time in the MDI [95.00 (pre) vs. 72.64 (1 year post) vs. 71.82 (3 years post), p < 0.0001], but no significant change between 1 and 3 years post-HSCT. There was no change in the Bayley Psychomotor Development Scale (PDI) [82.4 (pre) vs. 84.8 (1 year post), p = 0.68]. The PDI scores decreased over time [86.29 (pre) vs. 86 (1 year post) vs. 74.14 (3 years post), p = 0.045]. Although there was a decrease in scaled scores, there was not a loss of skills. Analysis of raw scores showed that there was an increase in the raw test scores, which indicated that these children acquired developmental skills, but at a slower rate than normal infants and toddlers. Younger children had a more significant decrease in adaptive scores compared with older children.

Conclusions

These findings may reflect the effects of the isolation and prolonged hospitalization that characterizes the immediate post-transplant period. Patients miss out on social interactions and learning opportunities that normally occur at their respective stages of development. These restrictions keep patients from acquiring developmentally appropriate cognitive skills as well as gross and fine motor developmental milestones. Longitudinal follow-up will be important to quantify acquisition of skills.
Literatur
6.
Zurück zum Zitat Phipps S, Brenner M, Heslop H, Kranec R, Jayawardene D, Mulhern R. Psychological effects of bone marrow transplantation on children and adolescents: preliminary report of a longitudinal study. Bone Marrow Transplant 1995;15:829–35.PubMed Phipps S, Brenner M, Heslop H, Kranec R, Jayawardene D, Mulhern R. Psychological effects of bone marrow transplantation on children and adolescents: preliminary report of a longitudinal study. Bone Marrow Transplant 1995;15:829–35.PubMed
7.
Zurück zum Zitat Simms S, Kazak AE, Golomb V, Goldwein J, Bunin N. Cognitive, behavioral and social outcome in survivors of childhood stem cell transplantation. J Pediatr Hematol Oncol 2002;25:5–7. Simms S, Kazak AE, Golomb V, Goldwein J, Bunin N. Cognitive, behavioral and social outcome in survivors of childhood stem cell transplantation. J Pediatr Hematol Oncol 2002;25:5–7.
8.
Zurück zum Zitat Phipps S, Dunavant M, Srivastava DK, Bowman L, Mulhern R. Cognitive and academic functioning in survivors of pediatric bone marrow transplantation. J Clin Oncol 2000;18:1004–11.PubMed Phipps S, Dunavant M, Srivastava DK, Bowman L, Mulhern R. Cognitive and academic functioning in survivors of pediatric bone marrow transplantation. J Clin Oncol 2000;18:1004–11.PubMed
9.
Zurück zum Zitat Cool VA. Long-term neuropsychological risks in pediatric bone marrow transplant: what do we know? Bone Marrow Transplant 1996;Suppl 3(18):S45–9. Cool VA. Long-term neuropsychological risks in pediatric bone marrow transplant: what do we know? Bone Marrow Transplant 1996;Suppl 3(18):S45–9.
12.
Zurück zum Zitat Perkins JL, Kunin-Batson AS, Youngren NM, et al. Long-term follow up of children who underwent hematopoietic cell transplant (HCT) for AML or ALL at less than 3 years of age. Pediatr Blood Cancer 2007;49:958–63. doi:10.1002/pbc.21207.PubMedCrossRef Perkins JL, Kunin-Batson AS, Youngren NM, et al. Long-term follow up of children who underwent hematopoietic cell transplant (HCT) for AML or ALL at less than 3 years of age. Pediatr Blood Cancer 2007;49:958–63. doi:10.​1002/​pbc.​21207.PubMedCrossRef
13.
Zurück zum Zitat Bayley N. Bayley scales of infant development—2nd. San Antonio: The Psychological Corporation; 1993. Bayley N. Bayley scales of infant development—2nd. San Antonio: The Psychological Corporation; 1993.
14.
Zurück zum Zitat Wechsler D. The Wechsler Preschool and Primary Scale of Intelligence—revised. San Antonio: The Psychological Corporation; 1989. Wechsler D. The Wechsler Preschool and Primary Scale of Intelligence—revised. San Antonio: The Psychological Corporation; 1989.
15.
Zurück zum Zitat Sparrow SS, Balla DA, Cicchetti DV. Vineland Adaptive Behavior Scales. American Guidance Service: Circles Pines, Minnesota; 1984. Sparrow SS, Balla DA, Cicchetti DV. Vineland Adaptive Behavior Scales. American Guidance Service: Circles Pines, Minnesota; 1984.
Metadaten
Titel
Long-Term Neurocognitive Function of Pediatric Patients with Severe Combined Immune Deficiency (SCID): Pre- and Post-Hematopoietic Stem Cell Transplant (HSCT)
verfasst von
Malinda Lin
Karen Epport
Colleen Azen
Robertson Parkman
Donald B. Kohn
Ami J. Shah
Publikationsdatum
01.03.2009
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 2/2009
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-008-9250-z

Weitere Artikel der Ausgabe 2/2009

Journal of Clinical Immunology 2/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.